MABTHERA conc perf 500 mg/50 ml flac 50 ml
7680543780251
CH-54378
L01FA01
07.16.1.
Active substances:
1 / 2
google
Details
- Product number
- 5437802
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- rituximabum 500 mg, natrii citras dihydricus, polysorbatum 80, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 263.2 mg.
Articles (1)
MabThera 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rituximabum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
263.2 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1267.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1998
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 54378
- Drug name
- MabThera, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 27/11/1997
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MABTHERA conc perf 500 mg/50 ml flac 50 ml
- Description (DE)
- MABTHERA Inf Konz 500 mg/50 ml Durchstf 50 ml
- Market launch
- 27/11/1997
- Narcotic (BTM)
- No